GP100 Intron 4 Peptide (VYFFLPDHL)
gp100/pmel, also known as pmel17, is a melanoma-associated differentiation antigen that is investigated as a target in melanoma immunotherapy.
| ￥500 | |
| RP30964-1 | |
|
|
|
|
|
|
|
|
|
| ￥500 | |
| RP30964-1 | |
|
|
|
|
|
|
|
|
|
gp100/pmel, also known as pmel17, is a melanoma-associated differentiation antigen that is investigated as a target in melanoma immunotherapy. |
| Synonyms | GP100 Intron 4 Peptide (VYFFLPDHL) |
| Description | gp100/pmel, also known as pmel17, is a melanoma-associated differentiation antigen that is investigated as a target in melanoma immunotherapy. |
| Sequence |
{Val}{Tyr}{Phe}{Phe}{Leu}{Pro}{Asp}{His}{Leu} |
| Sequence Shortening | VYFFLPDHL |
| Molecular Formula | C59H79N11O13 |
| Molecular Weight | 1150.35 |
| Length | 9 |
| Purity | >95% |
| Solubility | Soluble in dimethyl sulfoxide(Analytical grade) under 1mg/ml |
| Form | Lyophilized |
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
